Latest Insider Transactions at Altimmune, Inc. (ALT)
This section provides a real-time view of insider transactions for Altimmune, Inc. (ALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Altimmune, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Altimmune, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
14,449
+0.26%
|
-
|
|
Jun 13
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
720,878
+11.41%
|
-
|
|
May 16
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
767,728
+13.6%
|
-
|
|
May 15
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
274,703
+6.27%
|
-
|
|
Apr 16
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
700,066
+8.57%
|
-
|
|
Mar 15
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
261,969
+7.71%
|
-
|
|
Feb 15
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
67,925
+2.31%
|
-
|
|
Feb 13
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
269,527
+8.77%
|
-
|
|
Jan 17
2018
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
176,586
+6.51%
|
-
|
|
Dec 15
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
65,718
+2.71%
|
-
|
|
Dec 13
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
242,694
+9.57%
|
-
|
|
Nov 14
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
182,262
+8.17%
|
-
|